BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 33472522)

  • 21. COVID-19 in patients with rheumatological diseases in the Eastern Province of Saudi Arabia.
    Alqatari S; Nemer A; Hasan M; Bukhari R; Al Argan R; Al Khafaji D; Alwaheed A; Alzaki A; Al-Wazza M; Al Warthan S; Al Saeed A; Albeladi F; Almeer H; AlSulaiman R; Abu Quren A
    J Med Life; 2023 Jun; 16(6):873-882. PubMed ID: 37675163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of death in hospitalized patients with systemic lupus erythematosus: a 10-year multicenter nationwide Chinese cohort.
    Wu XY; Yang M; Xie YS; Xiao WG; Lin J; Zhou B; Guan X; Luo CN; Che N; Liu XZ; Wang C; Teng JL; Cheng XB; Ye JN; Su YT; Shi H; Yin YF; Liu MR; Sun Y; Hu QY; Zhou ZC; Chi HH; Liu Y; Zhang X; Chen JW; Zhang MJ; Zhao DB; Yang CD; Wu LJ; Liu HL
    Clin Rheumatol; 2019 Jan; 38(1):107-115. PubMed ID: 30123930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C; Kourilovitch MR; Molineros JE; Cardiel MH; Zurita L; Soroka NF; Yagur VY; Doukh N; Cervera R
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Juvenile systemic lupus erythematosus in Nigeria.
    Adelowo OO; Olaosebikan BH; Animashaun BA; Akintayo RO
    Lupus; 2017 Mar; 26(3):329-333. PubMed ID: 27771618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing trends in mortality in systemic lupus erythematosus? An analysis of SLE inpatient mortality at University Hospital Coventry and Warwickshire NHS Trust from 2007 to 2016.
    Anver H; Dubey S; Fox J
    Rheumatol Int; 2019 Dec; 39(12):2069-2075. PubMed ID: 31570977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.
    Feldman CH; Hiraki LT; Winkelmayer WC; Marty FM; Franklin JM; Kim SC; Costenbader KH
    Arthritis Rheumatol; 2015 Jun; 67(6):1577-85. PubMed ID: 25772621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival rates and risk factors for mortality in systemic lupus erythematosus patients in a Chinese center.
    Wu G; Jia X; Gao D; Zhao Z
    Clin Rheumatol; 2014 Jul; 33(7):947-53. PubMed ID: 24794488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.
    Feldman CH; Marty FM; Winkelmayer WC; Guan H; Franklin JM; Solomon DH; Costenbader KH; Kim SC
    Arthritis Rheumatol; 2017 Feb; 69(2):387-397. PubMed ID: 27589220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years.
    Chambers SA; Allen E; Rahman A; Isenberg D
    Rheumatology (Oxford); 2009 Jun; 48(6):673-5. PubMed ID: 19359343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study.
    Lerang K; Gilboe IM; Steinar Thelle D; Gran JT
    Lupus; 2014 Dec; 23(14):1546-52. PubMed ID: 25209070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the survival of patients with systemic lupus erythematosus in childhood: 30 years experience in Chile.
    González B; Hernández P; Olguín H; Miranda M; Lira L; Toso M; Quezada A; Norambuena X; Talesnik E; Méndez C; Navarrete C
    Lupus; 2005; 14(11):918-23. PubMed ID: 16335587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus.
    Kedves M; Kósa F; Kunovszki P; Takács P; Szabó MZ; Karyekar C; Lofland JH; Nagy G
    Rheumatology (Oxford); 2020 Nov; 59(11):3443-3451. PubMed ID: 32357240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unchanging premature mortality trends in systemic lupus erythematosus: a general population-based study (1999-2014).
    Jorge AM; Lu N; Zhang Y; Rai SK; Choi HK
    Rheumatology (Oxford); 2018 Feb; 57(2):337-344. PubMed ID: 29121273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Treatment Patterns and Associated Outcomes in Patients With Newly Diagnosed Systemic Lupus Erythematosus.
    Kan H; Nagar S; Patel J; Wallace DJ; Molta C; Chang DJ
    Clin Ther; 2016 Mar; 38(3):610-24. PubMed ID: 26907503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis.
    Ståhl-Hallengren C; Jönsen A; Nived O; Sturfelt G
    J Rheumatol; 2000 Mar; 27(3):685-91. PubMed ID: 10743809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease characteristics and causes of early and late death in a group of Croatian patients with systemic lupus erythematosus deceased over a 10-year period.
    Padjen I; Cerovec M; Erceg M; Mayer M; Stevanović R; Anić B
    Croat Med J; 2018 Feb; 59(1):3-12. PubMed ID: 29498492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992.
    Uramoto KM; Michet CJ; Thumboo J; Sunku J; O'Fallon WM; Gabriel SE
    Arthritis Rheum; 1999 Jan; 42(1):46-50. PubMed ID: 9920013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.
    Demir S; Artim-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Omma A; Erer B; Kamalı S; Gül A; Aral O; Öcal L; İnanç M
    Lupus; 2016 Feb; 25(2):177-84. PubMed ID: 26354963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.